This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wolfe, C. L. Articles by Scheinman, M. Search for Related Content PubMed PubMed Citation Articles by Wolfe, C. L. Articles by Scheinman, M.

Circulation, Vol 84, 1543-1551, Copyright © 1991 by American Heart Association

ARTICLES

Polymorphous ventricular tachycardia associated with acute myocardial infarction

CL Wolfe, C Nibley, A Bhandari, K Chatterjee and M Scheinman
Cardiovascular Research Institute, University of California, San Francisco.

BACKGROUND. During a 2.9-year period, 11 patients developed polymorphous ventricular tachycardia 1-13 days after acute anterior (seven patients) or inferior (four patients) myocardial infarction. None of the 11 patients had sinus bradycardia (mean heart rate, 90 +/- 23 beats/min), but three had a sinus pause immediately before the onset of polymorphous ventricular tachycardia. In all 11 patients, the QT interval and corrected QT interval (QTc) were normal or minimally prolonged (QT, 385 +/- 34 msec; QTc, 442 +/- 40 msec). None had significant hypokalemia (mean serum potassium concentration, 4.3 +/- 0.5 meq/l) or a grossly abnormal serum magnesium or calcium concentration (2.1 +/- 0.4 and 8.9 +/- 0.7 mg/dl, respectively). METHODS AND RESULTS. Immediately before the onset of polymorphous ventricular tachycardia, symptoms and/or electrocardiographic changes consistent with recurrent myocardial ischemia occurred in nine of 11 patients. One patient died before drug therapy could be initiated. Lidocaine was used in 10 patients and proved to be effective in only one. Intravenous procainamide was used in six patients: one improved, and five had recurrence of polymorphous ventricular tachycardia. Bretylium was used in five patients and was ineffective in all cases. Overdrive pacing was used in four patients and failed to suppress recurrent arrhythmias in all cases. Four patients with persistent polymorphous ventricular tachycardia unresponsive to lidocaine, procainamide, or bretylium responded to intravenous amiodarone. One patient with polymorphous ventricular tachycardia that was consistently preceded by ST segment elevation responded to intravenous nitroglycerin. Two patients with persistent polymorphous ventricular tachycardia and obvious recurrent ischemia unresponsive to pharmacological intervention responded to emergency coronary revascularization. A third patient who experienced recurrent angina and polymorphous tachycardia was initially stabilized with pharmacological therapy but subsequently underwent elective revascularization and has remained stable without antiarrhythmic therapy. CONCLUSIONS. Post- myocardial infarction polymorphous ventricular tachycardia is not consistently related to an abnormally long QT interval, sinus bradycardia, preceding sinus pauses, or electrolyte abnormalities. This arrhythmia has a variable response to class I antiarrhythmics but may be suppressed by intravenous amiodarone therapy. It is often associated with signs or symptoms of recurrent myocardial ischemia. Furthermore, coronary revascularization appears to be effective in preventing the recurrence of polymorphous ventricular tachycardia when associated with recurrent postinfarction angina.

This article has been cited by other articles:

				D. G. Katritsis and B. Meier Percutaneous Coronary Intervention for Stable Coronary Artery Disease J. Am. Coll. Cardiol., September 9, 2008; 52(11): 889 - 893. [Abstract] [Full Text] [PDF]

				Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]

				Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]

				A. Halkin, A. Roth, I. Lurie, R. Fish, B. Belhassen, and S. Viskin Pause-dependent torsade de pointes following acute myocardial infarction: A variant of the acquired long QT syndrome J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1168 - 1174. [Abstract] [Full Text] [PDF]

				A V Ghuran and A J Camm Ischaemic heart disease presenting as arrhythmias Br. Med. Bull., October 1, 2001; 59(1): 193 - 210. [Abstract] [Full Text] [PDF]

				S. M. Rivenes, D. L. Kearney, E. O'B. Smith, J. A. Towbin, and S. W. Denfield Sudden Death and Cardiovascular Collapse in Children With Restrictive Cardiomyopathy Circulation, August 22, 2000; 102(8): 876 - 882. [Abstract] [Full Text] [PDF]

				K. Nademanee, R. Taylor, W. E. Bailey, D. E. Rieders, and E. M. Kosar Treating Electrical Storm : Sympathetic Blockade Versus Advanced Cardiac Life Support-Guided Therapy Circulation, August 15, 2000; 102(7): 742 - 747. [Abstract] [Full Text] [PDF]

				A. N. Cheema, K. Sheu, M. Parker, A. H. Kadish, and J. J. Goldberger Nonsustained Ventricular Tachycardia in the Setting of Acute Myocardial Infarction : Tachycardia Characteristics and Their Prognostic Implications Circulation, November 10, 1998; 98(19): 2030 - 2036. [Abstract] [Full Text] [PDF]

				M. M. Scheinman, J. H. Levine, D. S. Cannom, T. Friehling, H. A. Kopelman, D. A. Chilson, E. V. Platia, D. J. Wilber, and P. R. Kowey Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias Circulation, December 1, 1995; 92(11): 3264 - 3272. [Abstract] [Full Text]